Wacker starts cystine production at new plants in Spain
Wacker Biosolutions, the life sciences division of the Wacker Group, has begun producing fermentation-generated cystine at its new site in León, Spain.
Wacker Biosolutions, the life sciences division of the Wacker Group, has begun producing fermentation-generated cystine at its new site in León, Spain. Over the past 18 months, the division has modernized part of the 800-cubic-meter fermentation capacity, which it acquired in 2016. In addition, it has built a production line for cystine. Wacker has invested approximately €30 million in the plants, which will be ramped up to full capacity over the next few months.
“With our investment in the León site, we are well equipped to further strengthen our position as the global market and technology leader for fermentation-generated cystine,” said Gerhard Schmid, head of Wacker Biosolutions. “The modernized fermentation plants and the new cystine production plant enable us to reliably meet our customers’ growing demand for cysteine and cystine, and to commercialize new fermentation-generated products.